• Making immunisation sustainable

in page functions
  • The goal of Gavi support is to ensure that countries can independently sustain high immunisation coverage and ensure equal access to life-saving vaccines

  • At Gavi we do not just help countries expand their national immunisation programmes. We also aim to make immunisation sustainable, both financially and programmatically.  This means ensuring that countries can sustain high coverage and equal access to vaccines after Gavi support ends. To achieve this, countries need to have their own robust systems and decision-making processes in place to introduce future, new vaccines, independent of the Vaccine Alliance.

    Our eligibility, transition and co-financing policies are at the core of Gavi’s approach to sustainability.  Our support is aimed at lower-income countries, it is time-limited and directly linked to the governments’ ability to pay for vaccines, depending on which phase of the Gavi transition process they have reached. Countries’ ability to pay is determined by their Gross National Income (GNI) per capita as calculated by the World Bank, Atlas method.

    • Eligibility

      Eligibility to apply for Gavi support is directly related to each country’s ability to pay as measured by its GNI per capita.
    • Co-financing

      Gavi-supported countries contribute to the cost of buying their own vaccines; their payments increase as GNI per capita rises.
    • Transitioning out of Gavi support

      Gavi works closely with countries to put them on a trajectory towards long-term programmatic and financial sustainability.
    • After Gavi support ends

      After countries transition from Gavi support, they can continue to procure through UNICEF or self-procure.
      Learn more  

    Countries enter Gavi support in the initial self-financing phase, where they pay a small amount towards their vaccine costs. When they move to the preparatory transition phase, the price fraction of their co-financing increases by 15% per year, after the grace year. As their GNI per capita grows, they enter the accelerated transition phase – a five-year period when co-financing reaches 100% of vaccine costs and phase-out from our support.

close icon

modal window here